Evidence map›Paper›PMID 20419313›Full record

ArticlePflugers Archiv : European journal of physiology2010

Ryanodol action on calcium sparks in ventricular myocytes.

Josefina Ramos-Franco, Ana M Gomez, Alma Nani, Yiwei Liu, Julio A Copello, Michael Fill

Abstract read
In one paragraph

Article in Pflugers Archiv : European journal of physiology, 2010. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
0.8field-weighted citation impact, top 25% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 12 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. A 15-step synthesis of (+)-ryanodol.Science (New York, N.Y.) · 2016
    Article
  6. Article
  7. Article
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 3 institutions in 2 countries.

Josefina Ramos-FrancoDepartment of Molecular Biophysics & Physiology, Rush University Medical Center, Chicago, IL 60612, USA.
Ana M Gomez
Alma Nani
Yiwei Liu
Julio A Copello
Michael Fill
Rush University Medical Center · USInserm · FRSouthern Illinois University School of Medicine · US

Funding

Limiting Pathological Calcium Induced Calcium Release in HeartR01HL057832 · NHLBI · RUSH UNIVERSITY MEDICAL CENTER · PI FILL, MICHAEL, GILLESPIE, DIRK · 1997 to 2024
$9.0M
Control of IP3R-Mediated Calcium ReleaseR01GM111397 · NIGMS · RUSH UNIVERSITY MEDICAL CENTER · PI CHEN, SUI RONG WAYNE, FILL, MICHAEL · 2015 to 2018
$1.6M
Communication neighboring ryanodine receptor channelsR01GM078665 · NIGMS · SOUTHERN ILLINOIS UNIVERSITY SCH OF MED · PI COPELLO, JULIO A · 2006 to 2010
$1.3M
LOCAL INTRACELLULAR CALCIUM RELEASE IN NEONATE HEARTR01HL071741 · NHLBI · RUSH UNIVERSITY MEDICAL CENTER · PI RAMOS-FRANCO, JOSEFINA · 2003 to 2006
$1.2M
REGULATION OF SINGLE CALCIUM RELEASE CHANNELS IN HEARTR01HL064210 · NHLBI · LOYOLA UNIVERSITY CHICAGO · PI FILL, MICHAEL · 2000 to 2003
$1.0M
NHLBI NIH HHS HL057832NHLBI NIH HHS HL064210NHLBI NIH HHS HL071741NHLBI NIH HHS R01 HL057832NHLBI NIH HHS R01 HL064210NHLBI NIH HHS R01 HL071741NIGMS NIH HHS GM078665NIGMS NIH HHS R01 GM078665
6 · The paper itself

Abstract

The action of ryanodol on single cardiac ryanodine receptor (RyR2) channels in bilayers and local RyR2-mediated Ca(2+) release events (Ca(2+) sparks) in ventricular myocytes was defined. At the single-channel level, ryanodol intermittently modified single channels into a long-lived subconductance state with an average duration of 3.8 +/- 0.2 s. Unlike ryanodine, ryanodol did not change the open probability (Po) of unmodified channels, and high concentrations did not promote full-channel closure. Ryanodol action was Po dependent with the K (D) varying roughly from 20 to 80 muM as Po changed from approximately 0.2 to 1, respectively. Ryanodol preferentially bound during long channel openings. In intact and permeabilized rat myocytes, ryanodol evoked trains of sparks at active release sites resulting in a significant increase in overall spark frequency. Ryanodol did not increase the number of active release sites. Long-lived Ca(2+) release events were observed but infrequently, and ryanodol action was readily reversed upon drug washout. We propose that ryanodol modifies a few channels during a Ca(2+) spark. These modified channels mediate a sustained low-intensity Ca(2+) release that repeatedly triggers sparks at the same release site. We conclude that ryanodol is an easily generated reversible probe that can be effectively used to explore RyR2-mediated Ca(2+) release in cells.

Indexed as

AnimalsCalcium SignalingDiterpenesHeart VentriclesMaleMicroscopy, ConfocalMuscle CellsRatsRats, WistarRyanodine Receptor Calcium Release ChannelSarcoplasmic ReticulumDiterpenesryanodanolRyanodine Receptor Calcium Release Channel

Identifiers

PMID20419313
PMCPMC3315696
OpenAlexW2003880038

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.